ANG

ANG Lifesciences India Share Price

 

 

Start SIP in ANG

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume

Investment Returns

  • Over 1 Month + 15.91%
  • Over 3 Month -17.85%
  • Over 6 Month + 4.54%
  • Over 1 Year -33.97%

Smart Investing Starts Here Start SIP with ANG Lifesciences India for Steady Growth!

Invest Now

ANG Lifesciences India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

ANG Lifesciences India Financials

ANG Lifesciences India Technicals

EMA & SMA

Current Price
₹29.50
+ 0.52 (1.79%)
  • Bearish Moving Average 0
  • Bullish Moving Average 0
  • 20 Day
  • ₹29.51
  • 50 Day
  • ₹29.91
  • 100 Day
  • ₹30.44
  • 200 Day
  • ₹32.80

Resistance and Support

29.13 Pivot Speed
  • R3 30.99
  • R2 30.25
  • R1 29.87
  • S1 28.75
  • S2 28.01
  • S3 27.63

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Angel One, trusted by over 2 crore clients, is a leading retail full-service broking house in India. Its Super App offers advanced tools like basket orders and SmartAPI, enabling seamless trading in stocks, mutual funds, IPOs, and more.

Angel One has an operating revenue of Rs. 4,660.51 Cr. on a trailing 12-month basis. An annual revenue growth of 23% is outstanding, Pre-tax margin of 30% is great, ROE of 20% is exceptional. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 44 which is a POOR score indicating inconsistency in earnings, a RS Rating of 68 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 82 indicates it belongs to a poor industry group of Finance-Investment Mgmt and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

ANG Lifesciences India Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-14 Quarterly Results
2025-08-14 Quarterly Results
2025-05-30 Audited Results
2025-02-14 Quarterly Results
2024-11-14 Quarterly Results
Date Purpose Remarks
2021-11-04 INTERIM Rs.1.00 per share(10%)Interim Dividend
View ANG Lifesciences India Dividend History Arrow
Date Purpose Remarks
2022-07-14 Bonus Rs.0.00 issue in the ratio of 1:4 of Rs. 10/-
2021-09-23 Bonus Rs.0.00 issue in the ratio of 1:1 of Rs. 10/-

ANG Lifesciences India F&O

ANG Lifesciences India Shareholding Pattern

28.91%
12.9%
0.5%
13.11%
0.03%
40.21%
4.34%

About ANG Lifesciences India

  • NSE Symbol
  • ANG
  • BSE Symbol
  • 540694
  • Chairman & Managing Director
  • Mr. Dinesh Thakkar
  • ISIN
  • INE236W01016

Similar Stocks to ANG Lifesciences India

ANG Lifesciences India FAQs

ANG Lifesciences India share price is ₹29 As on 26 December, 2025 | 03:51

The Market Cap of ANG Lifesciences India is ₹38.5 Cr As on 26 December, 2025 | 03:51

The P/E ratio of ANG Lifesciences India is -3.2 As on 26 December, 2025 | 03:51

The PB ratio of ANG Lifesciences India is 0.7 As on 26 December, 2025 | 03:51

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23